Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade

PTSD Clinical Trial

Official title: Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade

Status Withdrawn

Clinical Trial Summary

The main purpose is to show the percentage of patients taking antipsychotics with PTSD by looking at approximately ten year's worth of data from 1994 through 2004. We will also determine the type and dose of antipsychotics the patients received, and to determine how many of those patients had psychotic versus nonpsychotic symptoms. We will be obtaining this data from the VISN 7 Corporate Data Warehouse. We hypothesize that there has been an overall increase in antipsychotic use in patient's with PTSD over the last 10 years.

Clinical Trial Description

This study is a retrospective chart review of patients, at the Tuscaloosa VA Medical Center, who were, treated with antipsychotics as monotherapy or adjunctive therapy.

The data will be retrieved from a computerized list of patients treated at the TVAMC for PTSD from 1994-2004 Charts will be reviewed by looking at approximately ten year's worth of data. Charts will then be examined to determine what type of antipsychotics patients were prescribed, the dose and duration of the antipsychotics, and the presence or absence of documented psychotic symptoms. ;

Related Conditions & MeSH terms

• Disease
• Posttraumatic Stress Disorder
• PTSD
• Stress Disorders, Post-Traumatic
• Stress Disorders, Traumatic

• NCT number: NCT00233467
• Study type: Observational
• Source: Tuscaloosa Research & Education Advancement Corporation
• Status: Withdrawn
• Phase: N/A
• Start date: September 1, 2005
• Completion date: September 30, 2005